30 November 2023CompletedHealthcare
AbbVie Inc. to acquire ImmunoGen, Inc.
AbbVie Inc. and ImmunoGen, Inc. entered the Exit Mode archive.
- Buyer
- AbbVie Inc.
- Target
- ImmunoGen, Inc.
- Deal value
- USD 10,100,000,000
- Deal type
- going private
Buyer profile
AbbVie Inc.
Every published deal in the Exit Mode archive where this buyer appears on the acquiring side.
Country
United States
Deal count
1
Buyer type
Corporate / other
Aggregate disclosed value
Not stated
Keep browsing